Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Health Reform

Saturday Links

Posted on July 22, 2023July 22, 2023 by John C. Goodman
  • Gaming the patent system: drug companies have 74 patents apiece on America’s ten best-selling drugs—receiving over half of them after FDA approval.
  • More than 3.1 million patients in 48 states have completed a consultation with an AI-powered chatbot.
  • Federal employees are still not back to work. 17 of the 24 federal agencies in GAO’s review had an average occupancy of 25 percent or less.
  • As of mid-2020, collections agencies held $140 billion in unpaid medical bills. That’s more than all other collections agency consumer debt combined.
  • 80% of children with cancer survive at least five years in the wealthiest countries v. 30% in the rest of the world, according to WHO. (NYT)
+

Friday Links

Posted on July 21, 2023July 20, 2023 by John C. Goodman
  • Scott Atlas: what to expect for Medicare for All.
  • Unemployment reduces fertility. UI compensation reverses the effect.
  • Study:  OxyContin marketing in 1996 is related to adverse long-term health outcomes over twenty-five years later.
  • Brian J. Miller testimony: lawmakers should foster innovation in the medical field, to ensure the next generation of breakthrough technology reaches patients.
  • Medicaid health plans denied physician’s pre authorization requests one out of every eight times — roughly two times the rate under Medicare Advantage.
  • Yglesias:  Banning background checks increases racial discrimination.
+

The Atlantic: What Happens When Hard Drugs Are Decriminalized

Posted on July 20, 2023 by Devon Herrick

Today John Goodman posted the Danger of Drug Laws and the unintended consequences of making drug abuse illegal. Because drug abuse is illegal, illicit drug users don’t have the support system that medical pharmaceuticals have. For example, fentanyl has both legitimate medicinal uses and non-medical uses. It has a low therapeutic index when used for pain relief. That means it is inherently risky.

+

The Danger of Drug Laws

Posted on July 20, 2023 by John C. Goodman

When governments try to stop people from consuming politically disfavored intoxicants, they make consumption of those substances more dangerous by creating a black market in which purity and potency are highly variable and unpredictable….

The alarm about xylazine in fentanyl, which compounds the danger of fatal respiratory depression and may increase the risk of serious and persistent skin infections, is just the latest illustration of this predictable peril.

Jacob Sullum, Reason

+
  • Previous
  • 1
  • …
  • 313
  • 314
  • 315
  • 316
  • 317
  • 318
  • 319
  • …
  • 429
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 43 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom